05.20.24 -- Balancing Technology And The Human Touch

This report includes expert guidance on navigating development and manufacturing challenges with orphan drugs, with insights on how drug sponsors of all sizes work with CDMOs to achieve their goals.

Get a deeper look into how drug lipophilicity has evolved over time, its impact on drug development, and the need for new technology to enable new more complex drugs.

As we reflect on the past year, our insights serve as a beacon for driving innovation, fostering collaboration, and ultimately, advancing the collective goal of improving global healthcare outcomes.

Learn how the visualization of critical cellular responses can enable live-cell imaging to indicate effective payload delivery, increasing the potential of identifying clinically viable ADC leads.

Due to its therapeutic impact on a wide range of diseases and disorders, adeno-associated virus (AAV) gene therapy is one of the most promising advances in modern medicine.